Aims During the ongoing COVID-19 outbreak, co-circulation of other common respiratory
viruses can potentially result in co-infections; however, reported rates of co-infections for …

The global coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in an unprecedented …

Objectives Respiratory co‐infections have the potential to affect the diagnosis and treatment
of COVID‐19 patients. This meta‐analysis was performed to analyze the prevalence of …

The aim of this systematic review and meta‐analysis was to critically assess the published
literature related to community‐acquired viral co‐infections and COVID‐19 and to evaluate …

Objectives SARS-CoV-2 may cause acute lung injury, and secondary infections are thus
relevant complications in patients with COVID-19 pneumonia. However, detailed information …

Background: Co-infections of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) with respiratory viruses, bacteria and fungi have been reported to cause a wide range of …

Objectives The effect of SARS-CoV-2 on existing respiratory viruses in circulation and the
overall burden of viral respiratory disease remains uncertain. Traditionally, severe viral …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of
coronavirus disease 2019 (COVID-19), has infected all age groups and disproportionately …

Background Co‐infections, secondary bacterial or fungal infections, are important risk
factors for poor outcomes in viral infections. The prevalence of co‐infection and secondary …

Τhe COVID-19 pandemic highly impacted the circulation, seasonality, and morbidity burden
of several respiratory viruses. We reviewed published cases of SARS-CoV-2 and respiratory …